The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Green, M. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Green, M. F.
Related Collections
* Schizophrenia Spectrum Disorders
* Cognition

Am J Psychiatry 1996; 153:321-330
Copyright © 1996 by American Psychiatric Association


SPECIAL ARTICLES

What are the functional consequences of neurocognitive deficits in schizophrenia?

MF Green
Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Camarillo, CA 93011-6022, USA.

OBJECTIVE: It has been well established that schizophrenic patients have neurocognitive deficits, but it is not known how these deficits influence the daily lives of patients. The goal of this review was to determine which, if any, neurocognitive deficits restrict the functioning of schizophrenic patients in the outside world. METHOD: The author reviewed studies that have evaluated neurocognitive measures as predictors and correlates of functional outcome for schizophrenic patients. The review included 1) studies that have prospectively evaluated specific aspects of neurocognition and community (e.g., social and vocational) functioning (six studies), 2) all known studies of neurocognitive correlates of social problem solving (five studies), and 3) all known studies of neurocognitive correlates and predictors of psychosocial skill acquisition (six studies). RESULTS: Despite wide variation among studies in the selection of neurocognitive measures, some consistencies emerged. The most consistent finding was that verbal memory was associated with all types of functional outcome. Vigilance was related to social problem solving and skill acquisition. Card sorting predicted community functioning but not social problem solving. Negative symptoms were associated with social problem solving but not skill acquisition. Notably, psychotic symptoms were not significantly associated with outcome measures in any of the studies reviewed. CONCLUSIONS: Verbal memory and vigilance appear to be necessary for adequate functional outcome. Deficiencies in these areas may prevent patients from attaining optimal adaptation and hence act as "neurocognitive rate-limiting factors." On the basis of this review of the literature, a series of hypotheses are offered for follow-up studies.


This article has been cited by other articles:


Home page
Schizophr BullHome page
I. M. Hurford, S. R. Marder, R. S. E. Keefe, S. P. Reise, and R. M. Bilder
A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians
Schizophr Bull, September 23, 2009; (2009) sbp095v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
D. I. Velligan, M. Draper, D. Stutes, N. Maples, J. Mintz, S. Tai, and D. Turkington
Multimodal Cognitive Therapy: Combining Treatments That Bypass Cognitive Deficits and Deal With Reasoning and Appraisal Biases
Schizophr Bull, September 1, 2009; 35(5): 884 - 893.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
E. Granholm, D. Ben-Zeev, and P. C. Link
Social Disinterest Attitudes and Group Cognitive-Behavioral Social Skills Training for Functional Disability in Schizophrenia
Schizophr Bull, September 1, 2009; 35(5): 874 - 883.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
O. Robles, A. Zabala, I. Bombin, M. Parellada, D. Moreno, A. Ruiz-Sancho, and C. Arango
Cognitive Efficacy of Quetiapine and Olanzapine in Early-Onset First-Episode Psychosis
Schizophr Bull, August 25, 2009; (2009) sbp062v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. D. Ragland, A. R. Laird, C. Ranganath, R. S. Blumenfeld, S. M. Gonzales, and D. C. Glahn
Prefrontal Activation Deficits During Episodic Memory in Schizophrenia
Am J Psychiatry, August 1, 2009; 166(8): 863 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Fisher, C. Holland, M. M. Merzenich, and S. Vinogradov
Using Neuroplasticity-Based Auditory Training to Improve Verbal Memory in Schizophrenia
Am J Psychiatry, July 1, 2009; 166(7): 805 - 811.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. Bell, H. W. H. Tsang, T. C. Greig, and G. J. Bryson
Neurocognition, Social Cognition, Perceived Social Discomfort, and Vocational Outcomes in Schizophrenia
Schizophr Bull, July 1, 2009; 35(4): 738 - 747.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. S. Kern, R. P. Liberman, D. R. Becker, R. E. Drake, C. A. Sugar, and M. F. Green
Errorless Learning for Training Individuals With Schizophrenia at a Community Mental Health Setting Providing Work Experience
Schizophr Bull, July 1, 2009; 35(4): 807 - 815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Davidson, S. Galderisi, M. Weiser, N. Werbeloff, W. W. Fleischhacker, R. S. Keefe, H. Boter, I. P.M. Keet, D. Prelipceanu, J. K. Rybakowski, et al.
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
Am J Psychiatry, June 1, 2009; 166(6): 675 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
G. Brebion, R. A. Bressan, L. S. Pilowsky, and A. S. David
Depression, Avolition, and Attention Disorders in Patients with Schizophrenia: Associations with Verbal Memory Efficiency
J Neuropsychiatry Clin Neurosci, May 1, 2009; 21(2): 206 - 215.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. J. Cuesta, E. G. Jalon, M. S. Campos, and V. Peralta
Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis
The British Journal of Psychiatry, May 1, 2009; 194(5): 439 - 445.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. R. McGurk, K. T. Mueser, T. J. DeRosa, and R. Wolfe
Work, Recovery, and Comorbidity in Schizophrenia
Schizophr Bull, March 5, 2009; (2009) sbn182v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. S. Kern, S. M. Glynn, W. P. Horan, and S. R. Marder
Psychosocial Treatments to Promote Functional Recovery in Schizophrenia
Schizophr Bull, March 1, 2009; 35(2): 347 - 361.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
G. G. Brown, G. McCarthy, A. Bischoff-Grethe, B. Ozyurt, D. Greve, S. G. Potkin, J. A. Turner, R. Notestine, V. D. Calhoun, J. M. Ford, et al.
Brain-Performance Correlates of Working Memory Retrieval in Schizophrenia: A Cognitive Modeling Approach
Schizophr Bull, January 1, 2009; 35(1): 32 - 46.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. M. Silverstein, W. D. Spaulding, A. A. Menditto, A. Savitz, R. P. Liberman, S. Berten, and H. Starobin
Attention Shaping: a Reward-Based Learning Method to Enhance Skills Training Outcomes in Schizophrenia
Schizophr Bull, January 1, 2009; 35(1): 222 - 232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. A. Lewis, R. Y. Cho, C. S. Carter, K. Eklund, S. Forster, M. A. Kelly, and D. Montrose
Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia
Am J Psychiatry, December 1, 2008; 165(12): 1585 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Roffman, R. L. Gollub, V. D. Calhoun, T. H. Wassink, A. P. Weiss, B. C. Ho, T. White, V. P. Clark, J. Fries, N. C. Andreasen, et al.
MTHFR 677C -> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val -> Met
PNAS, November 11, 2008; 105(45): 17573 - 17578.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
E. S. Herbener
Emotional Memory in Schizophrenia
Schizophr Bull, September 1, 2008; 34(5): 875 - 887.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. R. E. Barnes, V. C. Leeson, S. H. Mutsatsa, H. C. Watt, S. B. Hutton, and E. M. Joyce
Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia
The British Journal of Psychiatry, September 1, 2008; 193(3): 203 - 209.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. A. R. Hodge, D. Siciliano, P. Withey, B. Moss, G. Moore, G. Judd, E. A. Shores, and A. Harris
A Randomized Controlled Trial of Cognitive Remediation in Schizophrenia
Schizophr Bull, August 20, 2008; (2008) sbn102v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. C. Goff
New Insights Into Clinical Response in Schizophrenia: From Dopamine D2 Receptor Occupancy to Patients' Quality of Life
Am J Psychiatry, August 1, 2008; 165(8): 940 - 943.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. Mohamed, R. Rosenheck, M. Swartz, S. Stroup, J. A. Lieberman, and R. S.E. Keefe
Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia
Am J Psychiatry, August 1, 2008; 165(8): 978 - 987.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. Harrow and T. H. Jobe
How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up
Schizophr Bull, July 9, 2008; (2008) sbn074v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
D. M. Barch, C. S. Carter, and the CNTRICS Executive Committee
Measurement Issues in the Use of Cognitive Neuroscience Tasks in Drug Development for Impaired Cognition in Schizophrenia: A Report of the Second Consensus Building Conference of the CNTRICS Initiative
Schizophr Bull, July 1, 2008; 34(4): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. K. Wynn, J. Lee, W. P. Horan, and M. F. Green
Using Event Related Potentials to Explore Stages of Facial Affect Recognition Deficits in Schizophrenia
Schizophr Bull, July 1, 2008; 34(4): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. J. Schmidt, D. S. Chapin, J. Cianfrogna, M. L. Corman, M. Hajos, J. F. Harms, W. E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson, et al.
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 681 - 690.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. K. Hill, J. L. Reilly, M. S. H. Harris, T. Khine, and J. A. Sweeney
Oculomotor and Neuropsychological Effects of Antipsychotic Treatment for Schizophrenia
Schizophr Bull, May 1, 2008; 34(3): 494 - 506.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
Y. Braw, Y. Bloch, S. Mendelovich, G. Ratzoni, G. Gal, H. Harari, A. Tripto, and Y. Levkovitz
Cognition in Young Schizophrenia Outpatients: Comparison of First-Episode With Multiepisode Patients
Schizophr Bull, May 1, 2008; 34(3): 544 - 554.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
D. Dickinson, J. M. Gold, F. B. Dickerson, D. Medoff, and L. B. Dixon
Evidence of Exacerbated Cognitive Deficits in Schizophrenia Patients With Comorbid Diabetes
Psychosomatics, April 1, 2008; 49(2): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
S. R. Marder
Neurocognition as a Treatment Target in Schizophrenia
Focus, April 1, 2008; 6(2): 180 - 183.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
Bibliography Schizophrenia
Focus, April 1, 2008; 6(2): 197 - 199.
[Full Text] [PDF]


Home page
FocusHome page
D. Turkington, D. Kingdon, and P. J. Weiden
Cognitive Behavior Therapy for Schizophrenia
Focus, April 1, 2008; 6(2): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
P. J. Conn, C. Tamminga, D. D. Schoepp, and C. Lindsley
Schizophrenia: Moving Beyond Monoamine Antagonists
Mol. Interv., April 1, 2008; 8(2): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. Catty, P. Lissouba, S. White, T. Becker, R. E. Drake, A. Fioritti, M. Knapp, C. Lauber, W. Rossler, T. Tomov, et al.
Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial
The British Journal of Psychiatry, March 1, 2008; 192(3): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
W. S. Stone and L. J. Seidman
Toward a Model of Memory Enhancement in Schizophrenia: Glucose Administration and Hippocampal Function
Schizophr Bull, January 1, 2008; 34(1): 93 - 108.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Psychiatry LawHome page
E. Schwalbe and A. Medalia
Cognitive Dysfunction and Competency Restoration: Using Cognitive Remediation to Help Restore the Unrestorable
J Am Acad Psychiatry Law, December 1, 2007; 35(4): 518 - 525.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
A. R. YUNG and P. D. McGORRY
Prediction of psychosis: setting the stage
The British Journal of Psychiatry, December 1, 2007; 191(51): s1 - s8.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. M. RODRIGUEZ-SANCHEZ, B. CRESPO-FACORRO, C. GONZALEZ-BLANCH, R. PEREZ-IGLESIAS, J. L. VAZQUEZ-BARQUERO, and the PAFIP Group Study
Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis
The British Journal of Psychiatry, December 1, 2007; 191(51): s107 - s110.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
B. T. Mausbach, P. D. Harvey, S. R. Goldman, D. V. Jeste, and T. L. Patterson
Development of a Brief Scale of Everyday Functioning in Persons with Serious Mental Illness
Schizophr Bull, November 1, 2007; 33(6): 1364 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. K. Schutt, L. J. Seidman, B. Caplan, A. Martsinkiv, and S. M. Goldfinger
The Role of Neurocognition and Social Context in Predicting Community Functioning Among Formerly Homeless Seriously Mentally Ill Persons
Schizophr Bull, November 1, 2007; 33(6): 1388 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. Morein-Zamir, D. C. Turner, and B. J. Sahakian
A Review of the Effects of Modafinil on Cognition in Schizophrenia
Schizophr Bull, November 1, 2007; 33(6): 1298 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. J. Sergi, M. F. Green, C. Widmark, C. Reist, S. Erhart, D. L. Braff, K. S. Kee, S. R. Marder, and J. Mintz
Social Cognition and Neurocognition: Effects of Risperidone, Olanzapine, and Haloperidol
Am J Psychiatry, October 1, 2007; 164(10): 1585 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. W. Buchanan, D. C. Javitt, S. R. Marder, N. R. Schooler, J. M. Gold, R. P. McMahon, U. Heresco-Levy, and W. T. Carpenter
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments
Am J Psychiatry, October 1, 2007; 164(10): 1593 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
T. E. Goldberg, R. S. Goldman, K. E. Burdick, A. K. Malhotra, T. Lencz, R. C. Patel, M. G. Woerner, N. R. Schooler, J. M. Kane, and D. G. Robinson
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Arch Gen Psychiatry, October 1, 2007; 64(10): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
D. Dickinson, A. S. Bellack, and J. M. Gold
Social/Communication Skills, Cognition, and Vocational Functioning in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1213 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. S. Brekke, M. Hoe, J. Long, and M. F. Green
How Neurocognition and Social Cognition Influence Functional Change During Community-Based Psychosocial Rehabilitation for Individuals with Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1247 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
P. D. Harvey, D. I. Velligan, and A. S. Bellack
Performance-Based Measures of Functional Skills: Usefulness in Clinical Treatment Studies
Schizophr Bull, September 1, 2007; 33(5): 1138 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. A. Gray and B. L. Roth
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1100 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. A. Geyer and C. A. Tamminga
Wayne Fenton's Impact on Academic Neuroscience
Schizophr Bull, September 1, 2007; 33(5): 1156 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
C. S. Carter and D. M. Barch
Cognitive Neuroscience-Based Approaches to Measuring and Improving Treatment Effects on Cognition in Schizophrenia: The CNTRICS Initiative
Schizophr Bull, September 1, 2007; 33(5): 1131 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. W. Buchanan, R. Freedman, D. C. Javitt, A. Abi-Dargham, and J. A. Lieberman
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1120 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
E. L. Stover, L. Brady, and S. R. Marder
New Paradigms for Treatment Development
Schizophr Bull, September 1, 2007; 33(5): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
H.-Y. Tan, J. H. Callicott, and D. R. Weinberger
Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia
Cereb Cortex, September 1, 2007; 17(suppl_1): i171 - i181.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. Burns
Evolution of outcome measures in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. S. Kraus and R. S. E. Keefe
Cognition as an outcome measure in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s46 - s51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. F. Green
Cognition, Drug Treatment, and Functional Outcome in Schizophrenia: A Tale of Two Transitions
Am J Psychiatry, July 1, 2007; 164(7): 992 - 994.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. S.E. Keefe, J. A. Sweeney, H. Gu, R. M. Hamer, D. O. Perkins, J. P. McEvoy, and J. A. Lieberman
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Am J Psychiatry, July 1, 2007; 164(7): 1061 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. Morrens, W. Hulstijn, and B. Sabbe
Psychomotor Slowing in Schizophrenia
Schizophr Bull, July 1, 2007; 33(4): 1038 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. W. Buchanan
Persistent Negative Symptoms in Schizophrenia: An Overview
Schizophr Bull, July 1, 2007; 33(4): 1013 - 1022.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Psychiatry LawHome page
S. K. Erickson, J. R. Ciccone, S. B. Schwarzkopf, J. S. Lamberti, and M. J. Vitacco
Legal Fallacies of Antipsychotic Drugs
J Am Acad Psychiatry Law, June 1, 2007; 35(2): 235 - 246.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
R. S. E. Keefe, R. M. Bilder, S. M. Davis, P. D. Harvey, B. W. Palmer, J. M. Gold, H. Y. Meltzer, M. F. Green, G. Capuano, T. S. Stroup, et al.
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
Arch Gen Psychiatry, June 1, 2007; 64(6): 633 - 647.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. S. Bellack, M. F. Green, J. A. Cook, W. Fenton, P. D. Harvey, R. K. Heaton, T. Laughren, A. C. Leon, D. J. Mayo, D. L. Patrick, et al.
Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop
Schizophr Bull, May 1, 2007; 33(3): 805 - 822.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. E. Simon, K. Cattapan-Ludewig, S. Zmilacher, D. Arbach, K. Gruber, D. N. Dvorsky, B. Roth, E. Isler, A. Zimmer, and D. Umbricht
Cognitive Functioning in the Schizophrenia Prodrome
Schizophr Bull, May 1, 2007; 33(3): 761 - 771.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
T. A. Niendam, C. E. Bearden, J. Zinberg, J. K. Johnson, M. O'Brien, and T. D. Cannon
The Course of Neurocognition and Social Functioning in Individuals at Ultra High Risk for Psychosis
Schizophr Bull, May 1, 2007; 33(3): 772 - 781.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
B. A. Cornblatt, A. M. Auther, T. Niendam, C. W. Smith, J. Zinberg, C. E. Bearden, and T. D. Cannon
Preliminary Findings for Two New Measures of Social and Role Functioning in the Prodromal Phase of Schizophrenia
Schizophr Bull, May 1, 2007; 33(3): 688 - 702.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
J. M. Noel
ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders
Am. J. Health Syst. Pharm., April 15, 2007; 64(8): 863 - 876.
[Full Text] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
D. L. Hake, E. Hamera, and M. Rempfer
Self-report of Cognitive Functioning and Learning in Schizophrenia
Journal of the American Psychiatric Nurses Association, April 1, 2007; 13(2): 93 - 100.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
D. I. Leitman, M. J. Hoptman, J. J. Foxe, E. Saccente, G. R. Wylie, J. Nierenberg, M. Jalbrzikowski, K. O. Lim, and D. C. Javitt
The Neural Substrates of Impaired Prosodic Detection in Schizophrenia and Its Sensorial Antecedents
Am J Psychiatry, March 1, 2007; 164(3): 474 - 482.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1996 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org